Technical and commercial operations mandates include roles at Bavarian Nordic to oversee late-stage vaccine programs for RSV and COVID-19. This role required guidance of cross-functional teams across Europe and the USA to execute a challenging development and launch strategy. The role also entailed commercial market aspects and an end-to-end strategy to safeguard a competitive advantage of the vaccines against established products. Similarly, a technical operations mandate at Intas Pharmaceuticals focused on guiding development and launch of the first European-approved Indian-made biosimilar. Responsibilities included management of CMC, supply chain, regulatory, pricing, partnering and out-licensing activities.